MARKET

VYGR

VYGR

Voyager Therapeutics Inc
NASDAQ
3.270
+0.050
+1.55%
After Hours: 3.270 0 0.00% 19:34 08/14 EDT
OPEN
3.220
PREV CLOSE
3.220
HIGH
3.290
LOW
3.135
VOLUME
306.19K
TURNOVER
--
52 WEEK HIGH
5.55
52 WEEK LOW
2.935
MARKET CAP
201.49M
P/E (TTM)
-1.8032
1D
5D
1M
3M
1Y
5Y
1D
Voyager’s New Alzheimer’s Trial Puts VYGR on Investors’ Early Watchlist
TipRanks · 2d ago
Canaccord Genuity Keeps Their Buy Rating on Voyager Therapeutics (VYGR)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Teleflex (TFX)
TipRanks · 6d ago
The Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Simply Wall St · 6d ago
Voyager Therapeutics (VYGR) Receives a Rating Update from a Top Analyst
TipRanks · 6d ago
Weekly Report: what happened at VYGR last week (0803-0807)?
Weekly Report · 6d ago
Voyager Therapeutics (VYGR) Stock Rebounds While Cash Runway Concerns Persist
Simply Wall St · 08/08 02:40
Voyager Therapeutics Reaffirmed Buy on Advancing Alzheimer’s Pipeline and 4Q26 Tau Program Catalysts; $8 Price Target Maintained
TipRanks · 08/07 13:45
More
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company engaged in leveraging the power of human genetics to modify the course of neurological diseases. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.

Webull offers Voyager Therapeutics Inc stock information, including NASDAQ: VYGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYGR stock methods without spending real money on the virtual paper trading platform.